Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
    • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Treatments
    • Research
    • Safety
    • COVID-19
    • ONS Congress
    • Clinical practice
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    Zoom Through Video Job Interviews With These Tips for Applicants and Hiring Managers
    nursing professional development
    Zoom Through Video Job Interviews With These Tips for Applicants and Hiring Managers
    January 22, 2021
    The Case of Concurrent Therapy Concerns
    Treatment side effects
    The Case of Concurrent Therapy Concerns
    December 18, 2020
    In a World Where You Can Be Anything, Be Kind
    Nurse staffing
    In a World Where You Can Be Anything, Be Kind
    December 11, 2020
    Nursing Innovation Links Rural Facilities to Resources and Experts to Provide High-Quality Care Across the Country
    Access to cancer care
    Nursing Innovation Links Rural Facilities to Resources and Experts to Provide High-Quality Care Across the Country
    December 04, 2020
    Why All Oncology Nurses Should Be Environmentalists
    Oncology nurse influence
    Why All Oncology Nurses Should Be Environmentalists
    November 27, 2020
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
    • Home

    Author Content

    Oncology Drug Reference Sheet: Selpercatinib
    Clinical practice

    Oncology Drug Reference Sheet: Selpercatinib

    In May 2020, the U.S. Food and Drug Administration gave accelerated approval for selpercatinib (Retevmo®) to treat RET-altered non-small cell lung cancer or thyroid cancer based on overall response rate and duration of response. Selpercatinib fights cancer by impeding RET protein activity. The determining clinical trial results demonstrated that it reduced tumor size in more than 50% of patients and was associated with fewer adverse reactions than other drugs that block the RET protein.

    November 24, 2020
    Intuitive Eating Creates Healthy Food Rituals
    Nurse self-care

    Intuitive Eating Creates Healthy Food Rituals

    Food connects us to other cultures, helps us celebrate life’s milestones, and nourishes our body. We spend hours of our day planning meals, cooking, and eating. With food at the center of our lives, a positive view of it promotes health and well-being, but many of us struggle with eating behaviors and weight management throughout our lifetime.

    November 17, 2020
    Use the Nursing Process to Create a Self-Care Plan
    Nurse self-care

    Use the Nursing Process to Create a Self-Care Plan

    Current events have given us an opportunity, and sometimes even a necessity, to rethink our well-being approaches. But developing a self-care plan doesn’t have to be overwhelming when you use a familiar method like the American Nurses Association’s nursing process.

    October 15, 2020
    Develop Your Individual Cancer Screening Plan
    Cancer screening

    Develop Your Individual Cancer Screening Plan

    As oncology nurses, we know that catching cancer early through screening leads to better outcomes and increased survival rates. We ask our survivors and loved ones to prioritize their cancer screenings, reminding them, “I do not want to see you in my clinic chair or hospital bed with cancer, especially not at an advanced level.” Take care of yourself by giving yourself the same lecture.

    June 29, 2020
    Be Honest: Are You Getting Enough Sleep?
    Nurse self-care

    Be Honest: Are You Getting Enough Sleep?

    A full night’s sleep is a necessity, not a luxury, yet many people place sleep at the end of their priority list. Rather than seeing it as restorative, they think it takes up precious time to be productive. Many proudly proclaim, “You can sleep when you’re dead,” but ignoring healthy sleep habits can actually bring people closer to that end. Insufficient sleep is so pervasive in the United States that the Centers for Disease Control and Prevention considers it a public health epidemic.

    May 28, 2020
    Oncology Drug Reference Sheet: Daratumumab
    Oncology drug research

    Oncology Drug Reference Sheet: Daratumumab

    Daratumumab (Darzalex®) was originally approved by the U.S. Food and Drug Administration in 2015 with additional indications added since. The most recent new indication was approved in September 2019 for newly diagnosed patients with multiple myeloma who are eligible for autologous stem cell transplantation. In May 2020, daratumumab and hyaluronidase-fihj (Darzalex Faspro™), a subcutaneous (SQ) formulation, was approved.

    April 28, 2020
    Emotional Coping Strategies for COVID-19
    Clinical practice

    Emotional Coping Strategies for COVID-19

    The COVID-19 novel coronavirus pandemic is turning the world, inside and outside of the hospital, upside down. Not only are oncology nurses seeing high demands at work, but changes and restrictions are being instated at home as well.

    March 16, 2020
    COVID-19 Telephone Triage for Patients With Cancer
    Clinical practice

    COVID-19 Telephone Triage for Patients With Cancer

    During the COVID-19 novel coronavirus pandemic, patients might be fearful and uncertain if they should come to their clinic appointments. COVID-19 presents greater risks to older adults and people with comorbid diseases such as cancer and other chronic conditions, and patient concerns will likely increase the volume of phone calls into your clinics and telephone triage lines. Oncology nurses can use the opportunity to assess and educate patients.

    March 13, 2020
    Why You Need to Use Your Vacation Benefits
    Nurse self-care

    Why You Need to Use Your Vacation Benefits

    Vacations can take many forms. Some are focused on pursuing thrill in far off places, whereas others are all about rest, whether at home or in an exotic locale. But all vacation takers are seeking the same outcome: better health and well-being when they return. This can translate into personal and professional benefits such as a better attitude, increased focus, and improved outlook on life. So why does the average American leave approximately four employer-paid vacation days on the table each year?

    February 21, 2020
    Oncology Drug Reference Sheet: Erdafitinib
    Treatments

    Oncology Drug Reference Sheet: Erdafitinib

    Erdafitinib (Balversa™) is the first targeted therapy that the U.S. Food and Drug Administration approved for treatment of metastatic bladder cancer. 

    September 24, 2019
    Oncology Drug Reference Sheet: Atezolizumab’s Indications for Breast and Lung Cancer
    Treatments

    Oncology Drug Reference Sheet: Atezolizumab’s Indications for Breast and Lung Cancer

    The U.S. Food and Drug Administration (FDA) first approved atezolizumab (Tecentriq®) in 2016, but it received additional approvals when used in combination treatments for locally advanced or metastatic triple negative breast cancer (TNBC) and small cell lung cancer (SCLC) in March 2019.

    July 23, 2019
    Practice These Five Self-Care Strategies in Less Than Five Minutes
    Nurse self-care

    Practice These Five Self-Care Strategies in Less Than Five Minutes

    Oncology nursing is a rewarding profession that offers nurses opportunities to build meaningful relationships with patients and families, manage complex patient situations, and provide compassionate care during a scary time in someone’s life. But what makes oncology nursing so special can also make nurses more vulnerable to occupational stress, which can lead to compassion fatigue or burnout.   

    May 25, 2019
    Oncology Drug Reference Sheet: Ribociclib
    Clinical practice

    Oncology Drug Reference Sheet: Ribociclib

    Ribociclib is a CDK 4/6 inhibitor first approved by the U.S. Food and Drug Administration in early 2017 for postmenopausal women with HR-positive, HER2-negative advanced or metastatic breast cancer in combination with an aromatase inhibitor as initial endocrine therapy, based on the MONALEESA trial results. 

    February 26, 2019
    Opioids Have Been a Healthcare Concern Since the 1980s
    Pain management

    Opioids Have Been a Healthcare Concern Since the 1980s, but Here’s How Nurses Can Help

    Although the opioid crisis was formally labeled a public health emergency in late 2017, excess drug abuse beyond prescription directions has been a public health concern for much longer—since the 1980s, in fact. At the November 2018 Center for Advancing Palliative Care Annual Seminar in Orlando, FL, speakers Lynn Hallarman and Mary McPherson presented a session on how the opioid crisis came to be and what our role as nurses is in changing culture and ultimately addressing it.

    January 22, 2019
    Reality-Based Leadership Helps Nurses Cut the Drama So They Can Problem Solve
    Nurse self-care

    Reality-Based Leadership Helps Nurses Cut the Drama So They Can Problem Solve

    Nurses spend an average of 2.5 hours per day on drama per staff person, according to Cy Wakeman, the opening keynote speaker at the 2018 American Nurses Credentialing Center’s Magnet Conference in Denver, CO, in October. That’s right, take 2.5 and multiply it by how many staff are working that day. 

    December 18, 2018
    How Advanced Practice Nurses Can Recognize It; Report It in an Era of Fast-Track Drug Approvals
    Advanced practice nursing (APN)

    How Advanced Practice Nurses Can Recognize It; Report It in an Era of Fast-Track Drug Approvals

    It takes an average of 12 years to move a drug from a new application to approval for a specific indication. Twelve years of clinical trials, documentation of several endpoints, and data surrounding incidence of observed adverse events and expected severity. Twelve years until a broader subset of patients can access the drug. 

    September 20, 2018
    How APRNs Can Support Patients During Oral Agent Treatment
    Advanced practice nursing (APN)

    How APRNs Can Support Patients During Oral Agent Treatment

    Oral agents offer many patient benefits, one of which is the freedom to take the medication at home, allowing them to keep their daily routine and gain additional time and independence they would have spent traveling to the clinic for treatment. However, with that freedom comes additional patient responsibilities, and preparation from advanced practice RNs (APRNs) is necessary to ensure patients can self-manage symptoms and adhere to administration regimens. Research shows that patients experience severe symptoms on oral agents that may cause them to miss as many as one-third of the prescribed doses. How can APRNs empower patients to adhere to the treatment plan and ensure safe symptom self-management at home? 

    August 16, 2018

    To discuss the information in this article with other oncology nurses, visit the ONS Communities.

    To report a content error, inaccuracy, or typo, email pubONSVoice@ons.org.

    Erin Dickman MS, RN, OCN®
     
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap

  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • Oncology Nursing Foundation
  • ONCC
    • © Copyright 2021 Oncology Nursing Society
     
    Back to Top ▲